Publicaciones › Edema macular diabético y sus tratamientos
Islets persisting on OCT macular thickness map after intravitreal injections unmask telangiectatic capillaries (TelCaps) in diabetic macular edema
Islotes que persisten en el mapa de grosor macular de OCT después de inyecciones intravítreas descubren capilares telangiectásicos (TelCaps) en edema macular diabético
| Año | 2026 |
|---|---|
| Fuente | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie |
| Tipo | article · Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't |
| Autores (10) | Bénédicte Dupas, Daniela Castro Farias, Giuseppe Querques, Paolo Forte, Jean-François Girmens, Aude Couturier, Ali Erginay, Marie-Noëlle Delyfer, Michel Paques, TelCaps Study Group |
| Posición de Erginay | 7 de 10 |
| Citas | 1 (OpenAlex) |
| Enlaces | DOI 10.1007/s00417-025-07095-y · PubMed 41586917 · OpenAlex · Texto completo en acceso abierto |
| Líneas | Cribado, telemedicina (OPHDIAT) y epidemiología de la retinopatía diabética Edema macular diabético y sus tratamientos Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión Imagen retiniana: OCT, OCT-angiografía y ultra-gran campo |
En pocas palabras
Se estudió cómo identificar capilares telangiectásicos en pacientes con edema macular diabético después de inyecciones intravítreas. Utilizando mapas de grosor macular de tomografía de coherencia óptica (OCT), se encontraron áreas de grosor retiniano persistente, llamadas islas, que frecuentemente coincidían con capilares telangiectásicos residuales. Estos hallazgos pueden ayudar a predecir la recurrencia del edema central.
Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.
Resumen original
PURPOSE: Recurrence of macular edema after intravitreal injections (IVI) may result from persistent focal microvascular abnormalities such as telangiectatic capillaries (TelCaps), which can be difficult to detect within a thickened retina. This study proposes a simple screening strategy to identify TelCaps using optical coherence tomography (OCT) thickness maps following anti-VEGF treated for diabetic macular edema (DME). METHODS: This is an ancillary study from the TalaDME double-blind randomized controlled trial evaluating the benefit of adjunctive focal laser photocoagulation to anti-VEGF therapy in eyes with DME and TelCaps. OCT imaging was performed monthly and indocyanine green angiography (ICGA) quarterly over 12 months. Twenty-eight fellow eyes that had recovered from center-involved DME (CI-DME) associated with TelCaps were analyzed. TelCaps were identified as late-phase hyperfluorescent lesions on ICGA. The topography of perifoveal retinal thickening on OCT and its spatial correlation with TelCaps were assessed. RESULTS: Following IVI induced resolution of central DME (defined as central macular thickness < 315 µm), OCT mapping revealed 52 perifoveal thickening spots, herein referred to as islets. TelCaps were located within 100 µm of the barycenter of 47/52 (90%) islets, observed in 27/28 (98%) eyes. During follow-up, 25 (89%) eyes showed islets enlargement, with 20 (71%) progressing to involve the fovea. All cases of central DME recurrence occurred in eyes with post-IVI islets, and recurrent edema was topographically continuous with these islets. No recurrence was observed in eyes with documented TelCaps occlusion. CONCLUSION: Following anti VEGF treatment for CI-DME associated with TelCaps, OCT thickness mapping can reveal islets of retinal thickening that frequently colocalize with residual TelCaps, potentially heralding recurrence of central edema. A systematic search for these islets may facilitate the diagnosis of TelCaps.